The House voted Tuesday night to reject a GOP-led effort to censure Del. Stacey Plaskett for "inappropriate coordination with convicted sex offender Jeffrey Epstein during a congressional hearing" in 2019.
The flight disruptions during the record government shutdown that ended last week inspired a rare act of bipartisanship in Washington on Tuesday, when congressional representatives from both parties introduced legislation that would allow air traffic controllers to get paid during future shutdowns.
Two men face charges in North Carolina after authorities say they used their vehicles to ram into ICE and Border Patrol agents who were taking part in President Trump's latest immigration surge in Charlotte.
The Federal Reserve's top banking regulator on Tuesday released new guidelines for the agency's supervision of the financial system, earning praise from industry trade groups and criticism from her predecessor.
A South Carolina bill that would allow judges to sentence women who get abortions to decades in prison and could restrict the use of IUDs and in vitro fertilization has stalled after failing to get out a legislative subcommittee Tuesday.
A band of Democratic lawmakers is urging members of the U.S. military to defy orders from President Trump and Defense Secretary Pete Hegseth if the orders are illegal.
Both Democrats and Republicans alike readied for a unanimous House vote Tuesday to pass a bill to force the release of the case files on the convicted sex offender Jeffrey Epstein. But in the end, one lawmaker stood alone in opposition: Republican Rep. Clay Higgins.
A U.S. appeals court on Tuesday paused a California law set to take effect in January requiring large companies to report every two years on how climate change could hurt them financially.
Plea negotiations with a Wisconsin judge accused of helping an immigrant evade federal agents are underway as her trial nears, the newly minted federal prosecutor overseeing the case said Tuesday.
Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy 0.25 mg and 0.5 mg injections and Ozempic will be $199 a month for new self-pay patients until March 31, 2026, Novo Nordisk...